Presents news items concerning the biotechnology industry, as of December 2001. European Court of Justice's move to uphold EU Directive 98/44/EC covering the patenting of biological material; Eli Lilly & Co.'s receipt of an approval letter from the U.S. Food and Drug Administration for its sepsis drug Xigris; Increase in healthcare mergers and acquisitions.